Methylphenidate Hydrochloride Tablet, Extended Release
Product Images NDC 13811-710

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Methylphenidate Hydrochloride (NDC 13811-710). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Trigen Laboratories, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Methylphenidate Hydrochloride Extended Release Tab 1)

Chemical structure of methylphenidate hydrochloride, showing the molecular arrangement of atoms including a phenyl ring, ester group, piperidine ring, and hydrochloride association.*

FDA Label Image

Figure 1 (Methylphenidate Hydrochloride Extended Release Tab 2)

A line graph comparing mean plasma methylphenidate concentration (ng/mL) over time (hours) between extended-release Methylphenidate HCl tablets 18 mg taken once daily and immediate-release Methylphenidate 5 mg taken three times daily.*

FDA Label Image

Figure 2 (Methylphenidate Hydrochloride Extended Release Tab 3)

Bar chart comparing maximum symptoms on the Inattention/Overactivity Scale between methylphenidate hydrochloride extended-release tablets once daily and placebo across three studies. Each study shows lower symptom scores for the methylphenidate group compared to placebo, with values plotted along a vertical scale from no symptoms (0) to maximum (15). Study 3 data is from week 4.*

FDA Label Image

Figure 3 (Methylphenidate Hydrochloride Extended Release Tab 4)

Line graph showing Combined Attention Subscale scores over 12 hours post initial dose comparing methylphenidate hydrochloride extended-release tablets and placebo. The y-axis ranges from more attentive to less attentive, with methylphenidate data represented by circles and placebo by crosses, indicating trends in attention levels over time in a clinical study.*

FDA Label Image

Tirgen Logo (Methylphenidate Hydrochloride Extended Release Tab 5)

FDA Label Image

Trigen Logo (Methylphenidate Hydrochloride Extended Release Tab 6)

FDA Label Image

Methylphenidate 18 mg 100ct Bl 200195-2 Rev. 10/2025 (Methylphenidate Hydrochloride Extended Release Tab 7)

Label for Methylphenidate Hydrochloride extended-release tablets, USP 18 mg, manufactured for Trigen Laboratories, LLC. The label indicates a package of 100 tablets, Rx only, with storage instructions and a barcode. It includes a pharmacist instruction to dispense the Medication Guide separately.*

FDA Label Image

Methylphenidate 27 mg 100ct Bl 200196-2 Rev. 10/2025 (Methylphenidate Hydrochloride Extended Release Tab 8)

Drug Facts panel for Methylphenidate Hydrochloride extended-release tablets, USP, 27 mg strength. Includes storage instructions, dosing note to see prescribing information, dispensing advice for pharmacists, and manufacturer info for Trigen Laboratories, LLC. Package contains 100 tablets, Rx only.*

FDA Label Image

Methylphenidate 36 mg 100ct Bl 200197-2 Rev. 10/2025 (Methylphenidate Hydrochloride Extended Release Tab 9)

Label for Methylphenidate Hydrochloride extended-release tablets, USP, 36 mg strength. The label includes dosage form, quantity of 100 tablets, and indicates Rx only. It shows storage instructions, a reminder to keep out of reach of children, and that the medication guide should be given to pharmacists. Manufactured for Trigen Laboratories, LLC, Alpharetta, GA, with their logo and website address.*

FDA Label Image

Methylphenidate 54 mg 100ct Bl 200198-2 Rev. 10/2025 (Methylphenidate Hydrochloride Extended Release Tab 10)

Label for Methylphenidate Hydrochloride extended-release tablets, USP, 54 mg strength. The label indicates 100 tablets per container, prescription use only, with storage instructions and warnings. It is manufactured for Trigen Laboratories, LLC, Alpharetta, GA. The label features the NDC number 13811-709-10 and includes a barcode.*

FDA Label Image

Methylphenidate 72 mg 30ct Bl Rev. 11/2021 (Methylphenidate Hydrochloride Extended Release Tab 11)

Label for Methylphenidate Hydrochloride extended-release tablets, USP, 72 mg strength. Contains 100 tablets in the package. The label includes storage instructions, a refill warning, the NDC number 13811-710-10, and manufacturer information for Trigen Laboratories, LLC, Alpharetta, GA. The label advises pharmacists to dispense the Medication Guide separately to each patient.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.